Patents Assigned to VivaScan Corporation
  • Patent number: 7003337
    Abstract: An improved method for non-invasively measuring a concentration of a target analyte dissolved in a fluid flowing through a sample is presented. It includes directing a probe beam of electromagnetic radiation, consisting of time multiplexed components of different wavelengths, through the sample and measuring the difference of the absorption of the radiation at at least one wavelength pair at different sample states. During sample state changes, the amount of fluid containing the target analyte within the sample is changing, which varies the total amount of target analyte in the sample, as well as the absorption properties of the sample. The sample states are produced, for instance, by compressing and uncompressing the tissue sample. The accuracy of the presented method is enhanced by including continuous estimation of the amount of the fluid containing the target analyte within the sample, and measurement of the variations of the absorption at a wavelength at which the target analyte absorbs significantly.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: February 21, 2006
    Assignee: VivaScan Corporation
    Inventors: Hannu Harjunmaa, Stevan Kun, Robert A. Peura, John A. Rolls
  • Patent number: 5372135
    Abstract: The present invention relates to the determination of an analyte or multiple analytes in blood using information derived from the differential optical absorption spectra of blood. Specifically, the information is derived from the differential spectra of tissue before and immediately after the volume of blood in the tissue has been changed.
    Type: Grant
    Filed: March 21, 1994
    Date of Patent: December 13, 1994
    Assignee: VivaScan Corporation
    Inventors: Yitzhak Mendelson, Hannu Harjunmaa, Yi Wang, Brian D. Gross
  • Patent number: 5277181
    Abstract: The present invention relates to the noninvasive measurement of blood hematocrit and hemoglobin content using differential optical absorption of two or more wavelengths of light during blood volume changes. The method is also useful for noninvasive measurements of other blood analytes, such as glucose, where variations in hematocrit or blood hemoglobin concentration cause errors in the measurement.
    Type: Grant
    Filed: December 12, 1991
    Date of Patent: January 11, 1994
    Assignee: VivaScan Corporation
    Inventors: Yitzhak Mendelson, Yi Wang, Brian D. Gross
  • Patent number: 5183042
    Abstract: To deterine glucose or other constituents of the human or animal body, near-infrared radiation containing two alternating wavelengths that have equal extinction coefficients in the tissue is directed onto a sample area of the body. The intensity relation of the two different wavelengths is adjusted so as to balance the two wavelength detected signals. The extracellular-to-intracellular fluid ratio of the tissue is changed or is allowed to change, and the alternating component of the transmitted beam power is measured. The amplitude of the alternating-current (AC) signal given by the detector represents glucose concentration or the difference from a preset reference concentration.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: February 2, 1993
    Assignee: Vivascan Corporation
    Inventors: Hannu Harjunmaa, Yitzhak Mendelson, Yi Wang
  • Patent number: 5178142
    Abstract: To determine glucose or other constituents of the human or animal body, a stabilized near-infrared radiation beam containing two alternating wavelengths that have approximately equal extinction coefficients in the tissue, is directed onto the sample area, the transmitted signal alternating component is zeroed by tuning one of the wavelengths, the extracellular-to-intracellular fluid ratio of the tissue is changed by exerting varying mechanical pressure on the tissue, or the ratio is allowed to change as a result of the natural pulsation. The alternating component of the transmitted beam power is measured in the changed fluid ratio state. The amplitude of the alternating-current (AC) signal given by the detector, is taken to represent glucose concentration or the difference from a preset reference concentration.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: January 12, 1993
    Assignee: Vivascan Corporation
    Inventors: Hannu Harjunmaa, Yitzhak Mendelson, Yi Wang